Executive summary: This report documents the continuing growth and transition of the Western Region identified in the 2004 report by the Centre for Strategic Economic Studies (Sheehan and Wiseman 2004). It follows a number of reports about the Region (NIEIR 2004; LeadWest 2008), in each of which...

Nanotechnology is the latest in a series of general purpose technologies (GPT), earlier examples of which, have transformed household life, industry structure and firm performance. This paper traces the development to date of one of the first uses of nanotechnology to synthesise a new drug....

This study addresses the ongoing implications of the realignment of the pharmaceutical industry knowledge base ? from small molecule methods to new biomedical technologies ? for the competitive positions of traditional pharmaceuticalcompanies and biopharmaceutical start-ups. The theoretical...

Using the framework of the business model developed in Rasmussen (2007b) this paper presents an outline of the traditional pharmaceutical company business model, and how it has responded to the new biotechnology. Biotechnology is a radical innovation which has a very different technological...

The concept of a business model facilitates analysis of the way in which a firm derives economic value from a newly developed technology. Indeed Chesbrough and Rosenbloom (2002) have argued that it is the business model adopted, more so than the technology itself, which is critical to the...

The resource based view of Wernerfelt (1984), Barney (1986, 1991) and Deirickx and Cool (1989) suggests that firms can achieve sustainable competitive advantage through the accumulation of strategic assets that are hard to imitate, substitute or trade (Amit and Schoemaker 1993). It is also...

As countries, Canada and Australia have much in common. There is a shared heritage as new world British colonies and accordingly a similar culture, governmental institutions, living conditions, health and educational standards. Australia is somewhat smaller than Canada- its population of about...

The previous paper3 provided a comparison of the biomedical sectors in Australia and Canada based heavily on an analysis of biomedical alliances as well as a broader range of indicators. The analysis suggested that the industry in Canada is much larger and more substantially integrated into the...

As countries, Canada and Australia have much in common. There is a shared heritage as new world British colonies and accordingly a similar culture, governmental institutions, living conditions, health and educational standards. Australia is somewhat smaller than Canada - its population of about...

Innovation in the pharmaceutical industry raises structural questions for the participants about their future roles. New technologies, and especially biotechnology, have made the industry structure more complex. Broadly speaking these technologies have been directed at two problems. One is...